Featured Products & Services

1. Controlled Expansion Of Supercritical Solutions (CESS®) Technology 4/24/2023

   Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.

2. Pharmaceutical Development 4/24/2023

   Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.

3. Robotic Multi-Format Filling & Closing System 1/2/2020

   AST’s ASEPTiCell® is a flexible fill/finish system that can efficiently process medium-sized clinical and commercial batches while meeting all cGMP requirements for cleanliness and sterility.

4. Aidaptus® Manufacturing

   We are the exclusive manufacturing partner for this innovative auto-injector platform.

5. Injection Molding 8/24/2020

   Capabilities that improve efficiency and accelerate development.

   B. Braun's OEM Division offers a variety of in-house molding capabilities including injection molding, insert molding and over molding. They own a primary 400,000-square-foot U.S. plant that includes a 16,500-square-foot ISO Class 8 molding facility housing some of B. Braun’s 80 injection molding presses, which range from 55-330 tons.

6. A Breakthrough Solution For Biologics 8/25/2023

   Medicines are highly sensitive to primary packaging components, which can affect compatibility with container closure systems. Discover Alba® syringes, designed for sensitive biologics, including highly concentrated drugs vulnerable to silicone interaction and ophthalmic medications.

7. Prototypes and Pre-Production

   Experience and Expertise Matter

   West engineers take an innovative yet scientific approach to product prototyping and pre-production preparations.  The contract manufacturing design team incorporates years of engineering expertise in the design and fabrication of molded and assembled components to ensure a more efficient downstream manufacturing process. 

8. Sterile Formulation Development 7/1/2022

   With over 20 years of experience, PCI’s strength lies in our ability to manage products with unique challenges ranging from small molecules presenting with solubility issues or a labile molecule that is only stable as a liquid presentation for a short time.

9. Rapid Development Through Phase I CTM 1/28/2022

   Ascendia works with discovery-stage pharmaceutical companies to provide lab-scale formulations suitable for pre-clinical testing. We conduct pre-formulation assessments, bioavailability modeling, and formulation approach comparisons. We provide trial formulations suitable for animal studies, toxicology studies, and cGMP clinical trial materials for Phase I studies.

10. Blow-Fill-Seal Packaging Systems For Large Volume Nebulizers And Humidifiers 7/9/2020

    Large volume humidifiers and nebulizers – typically in sizes from 250 – 1000mL – can be specifically designed to fit existing delivery devices. Custom designs to facilitate the control of humidification in oxygen delivery can be developed.